<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01865110</url>
  </required_header>
  <id_info>
    <org_study_id>MCL R2 Elderly</org_study_id>
    <nct_id>NCT01865110</nct_id>
  </id_info>
  <brief_title>R-CHOP + R-HAD vs R-CHOP Followed by Maintenance Lenalidomide + Rituximab vs Rituximab for Older Patients With MCL</brief_title>
  <official_title>Efficacy of Alternating Immunochemotherapy Consisting of R-CHOP + R-HAD vs R-CHOP Alone, Followed by Maintenance Therapy Consisting of Additional Lenalidomide + Rituximab vs Rituximab Alone for Older Patients With Mantle Cell Lymphoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Lymphoma Academic Research Organisation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Lymphoma Academic Research Organisation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to evaluate whether the addition of lenalidomide to rituximab-maintenance
      improves progression free survival (PFS) compared to standard rituximab maintenance after
      induction treatment consisting of R-CHOP + R-HAD vs R-CHOP alone in older patients (≥ 60 year
      old) with mantle cell lymphoma.

      The treatments consist of two phases: induction treatment (3 R-CHOP21 + 3 cycles of R-HAD28
      alternating) vs 8 cycles of R-CHOP21) followed by maintenance treatment (13 cycles of
      rituximab + 26 cycles of lenalidomide vs 13 cycles of rituximab).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aims to evaluate whether the addition of lenalidomide to rituximab-maintenance
      improves progression free survival (PFS) compared to standard rituximab maintenance after
      induction treatment consisting of R-CHOP + R-HAD versus R-CHOP alone in older patients (≥ 60
      year old) with mantle cell lymphoma. 643 patients will be randomized in induction phase and
      433 in maintenance phase.

      The treatments consist of two phases:

        -  induction treatment will be 3 cycles of R-CHOP21 + 3 cycles of R-HAD28(alternating)
           versus 8 cycles of R-CHOP21 alone

        -  maintenance treatment will be 13 cycles of rituximab every 8 weeks + 26 cycles of
           lenalidomide every 4 weeks vs 13 cycles of rituximab every 8 weeks.

      Patients will be followed 2.5 years after the last patient randomized for maintenance for
      final analysis. All subjects who complete or discontinue the maintenance treatment for any
      reason will be followed for at least 3 years after his/her last study treatment
      administration in maintenance period for Second Primary Malignancies (SPM). A long term
      follow-up for progression/death will be done up to the end of period of SPM data collection.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">March 2024</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Progression free survival</measure>
    <time_frame>2.5 years</time_frame>
    <description>2.5 years after last patient randomized in maintenance</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">633</enrollment>
  <condition>Mantle Cell Lymphoma</condition>
  <arm_group>
    <arm_group_label>Induction experimental arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>R-CHOP / R-HAD : Alternating 3 cycles of R-CHOP administered in 3 week cycles + 3 cycles of R-HAD administered in 4 week cycles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standart induction arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>8 cycles of R-CHOP administered in 3 week cycles</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Maintenance experimental arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>lenalidomide + rituximab : 13 cycles of rituximab SC 1400 mg administered in 8 week cycles + 26 cycles Lenalidomide 15 mg 3 weeks every 4 weeks for 24 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Maintenance standart arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>13 cycles of rituximab SC 1400 mg administered in 8 week cycles for 24 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>R-CHOP</intervention_name>
    <description>R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone) administered in 3 week cycles for 8 cycles</description>
    <arm_group_label>Standart induction arm</arm_group_label>
    <other_name>rituximab, CHOP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>R-CHOP / R-HAD</intervention_name>
    <description>R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) administered in 3 week cycles for 3 cycles R-HAD (rituximab, cytarabine, dexamethasone) administered in 3 week cycles for 4 cycles alternating</description>
    <arm_group_label>Induction experimental arm</arm_group_label>
    <other_name>rituximab, CHOP</other_name>
    <other_name>rituximab HD AraC</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rituximab</intervention_name>
    <description>Rituximab SC 1400 mg every 8 weeks for 24 months</description>
    <arm_group_label>Maintenance experimental arm</arm_group_label>
    <arm_group_label>Maintenance standart arm</arm_group_label>
    <other_name>Mabthera</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lenalidomide</intervention_name>
    <description>Lenalidomide 15 mg 3 weeks every 4 weeks for 24 months</description>
    <arm_group_label>Maintenance experimental arm</arm_group_label>
    <other_name>Revlimid</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Signed informed consent form Biopsy-proven MCL according to WHO classification

        ≥ 60 years of age and ineligible for autologous transplant Ann Arbor stage II-IV Previously
        untreated ECOG PS ≤ 2

        Male subjects must:

          -  agree to use a condom during sexual contact with a woman of childbearing potential,
             even if they have had a vasectomy, throughout lenalidomide therapy

          -  agree to not donate semen during lenalidomide therapy.

        All subjects must:

          -  have an understanding that the lenalidomide could have a potential teratogenic risk.

          -  agree to abstain from donating blood while taking lenalidomide therapy

          -  agree not to share study medication with another person.

          -  be counselled about pregnancy precautions and risks of foetal exposure.

        Additional criteria for randomization in maintenance phase:

          -  CR, CRu or PR after induction treatment, determined as per Cheson 1999 criteria

          -  During the run-in period of 6 months starting from the date of the first randomization
             in the trial: in case of direct randomization into maintenance phase, patient must
             have been treated in first line by 6-8 cycles of R-CHOP.

        Exclusion Criteria:

        Female of childbearing potential

        Any of the following laboratory abnormalities at diagnosis, if not related to lymphoma:

        Absolute neutrophils count &lt;1,000 /mm3 Platelet count &lt; 75,000/mm3 AST/SGOT or ALT/SGPT
        &gt;3.0 UNL Serum total bilirubin &gt; 1.5 ULN (except if due to Gilbert's syndrome) Calculated
        creatinine clearance (Cockcroft-Gault formula or MDRD) &lt; 30 mL / min Central Nervous System
        involvement by lymphoma Contraindication for medical DVT prophylaxis for patients at high
        risk for DVT

        Prior history of malignancies other than MCL unless the subject has been free of the
        disease for ≥ 5 years. Exceptions include the following:

          -  Basal cell carcinoma or Squamous cell carcinoma of the skin

          -  Carcinoma in situ of the cervix or of the breast

          -  Incidental histologic finding of prostate cancer (TNM stage of T1a or T1b). Any
             serious medical condition, laboratory abnormality or psychiatric illness that would
             prevent the patient to receive the study medication as planned.

        Seropositivity for human immunodeficiency virus at study entry Seropositivity for hepatitis
        C virus at study entry,

        Active viral infection with hepatitis B virus at study entry:

          -  HBsAg positive

          -  HBsAg negative, anti-HBs positive and anti-HBc positive

        Uncontrolled illness including, but not limited to:

          -  Active infection requiring parenteral antibiotics.

          -  Uncontrolled diabetes mellitus

          -  Chronic symptomatic congestive heart failure (Class NYHA III or IV).

          -  Unstable angina pectoris, angioplasty, stenting, or myocardial infarction within 6
             months

          -  Clinically significant cardiac arrhythmia that is symptomatic or requires treatment,
             or asymptomatic sustained ventricular tachycardia.

        Prior ≥ Grade 3 allergic hypersensitivity to thalidomide. Prior ≥ Grade 3 rash or any
        desquamating (blistering) rash while taking thalidomide.

        Known anti-murine antibody (HAMA) reactivity or known hypersensitivity to murine
        antibodies.

        Subjects with ≥ Grade 2 neuropathy. Prior use of lenalidomide Participation in another
        clinical trial within three weeks before randomization in this study

        Additional criteria for randomization in maintenance phase:

          -  SD or PD after induction treatment determined as per Cheson 1999 criteria

          -  Patient treated by induction immuno-chemotherapy other than 6-8 cycle of R-CHOP21 or
             2-3 cycles of R-CHOP21 / 2-3 cycles of R-HAD28 (alternating)

          -  Patients with serious underlying medical conditions, which could impair the ability to
             receive maintenance treatment

          -  Calculated creatinine clearance of &lt; 30 mL / min

          -  ANC is &lt; 1,000 cells/mm³

          -  Platelet count is &lt; 50,000 cells/mm³
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Dreyling, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>MCL Network</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vincent Ribrag, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lymphoma Study Association</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Johanna Cornelia Kluin-Nelemans, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>MCL Network</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christine STEPHAN</last_name>
    <phone>+33 4 72 66 93 33</phone>
    <email>christine.stephan@lysarc.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>ZNA Stuivenberg</name>
      <address>
        <city>Antwerpen</city>
        <zip>2060</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre ZACHEE, MD</last_name>
      <email>pierre.zachee@zna.be</email>
    </contact>
    <investigator>
      <last_name>Pierre ZACHEE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>A. Z. Sint-Jan</name>
      <address>
        <city>Bruges</city>
        <zip>8000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sylvia SNAUWAERT, MD</last_name>
      <email>Sylvia.snauwaert@azsintjan.be</email>
    </contact>
    <investigator>
      <last_name>Sylvia SNAUWAERT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Jules Bordet</name>
      <address>
        <city>Bruxelles</city>
        <zip>1000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie MAEREVOET, MD</last_name>
      <email>marie.maerevoet@bordet.be</email>
    </contact>
    <investigator>
      <last_name>Marie MAEREVOET, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Université Catholique de Louvain Saint Luc</name>
      <address>
        <city>Bruxelles</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric VAN DEN NESTE, MD</last_name>
      <email>eric.vandenneste@uclouvain.be</email>
    </contact>
    <investigator>
      <last_name>Eric VAN DEN NESTE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Grand Hopital de Charleroi</name>
      <address>
        <city>Charleroi</city>
        <zip>6000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Delphine PRANGER, MD</last_name>
      <email>delphine.pranger@ghdc.be</email>
    </contact>
    <investigator>
      <last_name>Delphine PRANGER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AZ Groeninge</name>
      <address>
        <city>Kortrijk</city>
        <zip>8500</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Koenraad VAN EYGEN, MD</last_name>
      <email>koen.vaneygen@azgroeninge.be</email>
    </contact>
    <investigator>
      <last_name>Koenraad VAN EYGEN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Liège</name>
      <address>
        <city>Liège</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe BONNET, MD</last_name>
      <email>cbonnet@ulg.ac.be</email>
    </contact>
    <investigator>
      <last_name>Christophe BONNET, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de la Tourelle-Peltzer</name>
      <address>
        <city>Verviers</city>
        <zip>4800</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gaëtan VANSTRAELEN, MD</last_name>
      <email>gaetan.vanstraelen@chplt.be</email>
    </contact>
    <investigator>
      <last_name>Gaëtan VANSTRAELEN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Université Catholique de Louvain Mont Godinne</name>
      <address>
        <city>Yvoir</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc ANDRE, MD</last_name>
      <email>marc.andre@uclouvain.be</email>
    </contact>
    <investigator>
      <last_name>Marc ANDRE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU d'Amiens</name>
      <address>
        <city>AMIENS Cedex 1</city>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean Pierre MAROLLEAU</last_name>
      <email>marolleau.jean-pierre@chu-amiens.fr</email>
    </contact>
    <investigator>
      <last_name>Jean Pierre MAROLLEAU, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU d'Angers</name>
      <address>
        <city>Angers</city>
        <zip>49000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie-Pierre MOLES</last_name>
      <email>mpmoles@chu-angers.fr</email>
    </contact>
    <investigator>
      <last_name>Marie-Pierre MOLES, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH d Avignon - Hopital Henri Duffaut</name>
      <address>
        <city>Avignon Cedex 9</city>
        <zip>84902</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Borhane SLAMA</last_name>
      <email>Bslama@ch-avignon.fr</email>
    </contact>
    <investigator>
      <last_name>Borhane SLAMA, doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Côte Basque</name>
      <address>
        <city>Bayonne</city>
        <zip>64100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne BANOS</last_name>
      <email>abanos@ch-cotebasque.fr</email>
    </contact>
    <investigator>
      <last_name>Anne BANOS, doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Jean Minjoz</name>
      <address>
        <city>Besancon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean FONTAN</last_name>
      <email>jfontan@chu-besancon.fr</email>
    </contact>
    <investigator>
      <last_name>Jean FONTAN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de Blois</name>
      <address>
        <city>Blois</city>
        <zip>41000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Abderrazak EL YAMANI</last_name>
      <email>elyamaa@ch-blois.fr</email>
    </contact>
    <investigator>
      <last_name>Abderrazak EL YAMANI, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Bergonié</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna SCHMITT</last_name>
      <email>a.schmitt@bordeaux.unicancer.fr</email>
    </contact>
    <investigator>
      <last_name>Anna SCHMITT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Polyclinique Bordeaux Nord</name>
      <address>
        <city>Bordeaux</city>
        <zip>33300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier FITOUSSI</last_name>
      <email>o.fitoussi@bordeauxnord.com</email>
    </contact>
    <investigator>
      <last_name>Olivier FITOUSSI, doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH du Dr Duchenne</name>
      <address>
        <city>BOULOGNE SUR MER Cedex</city>
        <zip>62321</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bachra CHOUFI</last_name>
      <email>b.choufi@ch-boulogne.fr</email>
    </contact>
    <investigator>
      <last_name>Bachra CHOUFI, doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Morvan</name>
      <address>
        <city>Brest</city>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adrian TEMPESCUL</last_name>
      <email>adrian.tempescul@chu-brest.fr</email>
    </contact>
    <investigator>
      <last_name>Adrian TEMPESCUL, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Caen</name>
      <address>
        <city>Caen</city>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe FRUCHART</last_name>
      <email>fruchart-c@chu-caen.fr</email>
    </contact>
    <investigator>
      <last_name>Christophe FRUCHART, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MEDIPOLE de SAVOIE</name>
      <address>
        <city>Challes les Eaux</city>
        <zip>73190</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Selim CORM</last_name>
      <email>selim.corm@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Selim Corm</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Chambéry</name>
      <address>
        <city>Chambery</city>
        <zip>73011</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maya Hacini</last_name>
      <email>maya.hacini@ch-metropole-savoie.fr</email>
    </contact>
    <investigator>
      <last_name>Maya HACINI, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Antoine Beclere</name>
      <address>
        <city>Clamart</city>
        <zip>92140</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>François BOUE</last_name>
      <email>francois.boue@abc.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>François BOUE, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pôle Santé République</name>
      <address>
        <city>CLERMONT FERRAND Cedex 2</city>
        <zip>63050</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joël FLEURY</last_name>
      <email>jfleury@polesanterepublique.com</email>
    </contact>
    <investigator>
      <last_name>Joël FLEURY, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Estaing</name>
      <address>
        <city>Clermont Ferrand</city>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Victoria CACHEUX</last_name>
      <email>vcacheux@chu-clermontferrand.fr</email>
    </contact>
    <investigator>
      <last_name>Victoria CACHEUX, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Sud Francilien de Corbeil</name>
      <address>
        <city>Corbeil Essonnes</city>
        <zip>91108</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bertrand JOLY</last_name>
      <email>bertrand.joly@ch-sud-francilien.fr</email>
    </contact>
    <investigator>
      <last_name>Bertrand JOLY, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Henri Mondor</name>
      <address>
        <city>Creteil</city>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Corinne HAIOUN</last_name>
      <email>corinne.haioun@hmn.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Corinne HAIOUN, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Le Bocage</name>
      <address>
        <city>Dijon</city>
        <zip>21034</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier CASASNOVAS</last_name>
      <email>olivier.casasnovas@chu-dijon.fr</email>
    </contact>
    <investigator>
      <last_name>Olivier CASASNOVAS, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Dunkerque</name>
      <address>
        <city>Dunkerque</city>
        <zip>59385</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean Michel PIGNON</last_name>
      <email>jean-michel.pignon@ch-dunkerque.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Michel PIGNON, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Daniel Hollard</name>
      <address>
        <city>GRENOBLE Cedex 1</city>
        <zip>38028</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cécile LEYRONNAS</last_name>
      <email>c.leyronnas@ghm-grenoble.fr</email>
    </contact>
    <investigator>
      <last_name>Cécile LEYRONNAS, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Grenoble</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rémy GRESSIN</last_name>
      <email>rgressin@chu-grenoble.fr</email>
    </contact>
    <investigator>
      <last_name>Rémy GRESSIN, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Départemental</name>
      <address>
        <city>La Roche Sur Yon</city>
        <zip>85925</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hervé MAISONNEUVE</last_name>
      <email>herve.maisonneuve@chd-vendee.fr</email>
    </contact>
    <investigator>
      <last_name>Hervé MAISONNEUVE, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital André Mignot</name>
      <address>
        <city>Le Chesnay</city>
        <zip>78157</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hassan FARHAT, MD</last_name>
      <email>hfarhat@ch-versailles.fr</email>
    </contact>
    <investigator>
      <last_name>Hassan FARHAT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH du Mans</name>
      <address>
        <city>Le Mans</city>
        <zip>72000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kamel LARIBI</last_name>
      <email>klaribi@ch-lemans.fr</email>
    </contact>
    <investigator>
      <last_name>Kamel LARIBI, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Victor Hugo</name>
      <address>
        <city>Le Mans</city>
        <zip>72000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katell LE DÛ</last_name>
      <email>k.ledu@cjb72.org</email>
    </contact>
    <investigator>
      <last_name>Katell LE DÛ, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de Lens</name>
      <address>
        <city>Lens</city>
        <zip>62300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniela ROBU</last_name>
      <email>drobu@ch-lens.fr</email>
    </contact>
    <investigator>
      <last_name>Daniela ROBU, doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Claude Hurriez</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Franck MORSCHHAUSER</last_name>
      <email>franck.morschhauser@chru-lille.fr</email>
    </contact>
    <investigator>
      <last_name>Franck MORSCHHAUSER, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Leon Berard</name>
      <address>
        <city>Lyon Cedex 8</city>
        <zip>69373</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuelle NICOLAS-VIRELIZIER</last_name>
      <email>emmanuelle.nicolas@lyon.unicancer.fr</email>
    </contact>
    <investigator>
      <last_name>Emmanuelle NICOLAS- VIRELIZIER, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Paoli Calmette</name>
      <address>
        <city>Marseille</city>
        <zip>13273</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Reda BOUABDALLAH</last_name>
      <email>bouabdallahr@ipc.unicancer.fr</email>
    </contact>
    <investigator>
      <last_name>Reda BOUABDALLAH, doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de Meaux</name>
      <address>
        <city>Meaux</city>
        <zip>77104</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jamilé FRAYER</last_name>
      <email>j-frayfer@ch-meaux.fr</email>
    </contact>
    <investigator>
      <last_name>Jamilé FRAYFER, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de la Région Annecy-Genevois</name>
      <address>
        <city>Metz-Tessy</city>
        <zip>74374</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolas DAGUINDAU</last_name>
      <email>ndaguindau@ch-annecy.fr</email>
    </contact>
    <investigator>
      <last_name>Nicolas DAGUINDAU, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Bon Secours</name>
      <address>
        <city>Metz</city>
        <zip>57038</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe CARASSOU</last_name>
      <email>p.carassou@chr-metz-thionville.fr</email>
    </contact>
    <investigator>
      <last_name>Philippe CARASSOU, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Montpellier</name>
      <address>
        <city>MONTPELLIER Cedex 5</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guillaume CARTRON</last_name>
      <email>g-cartron@chu-montpellier.fr</email>
    </contact>
    <investigator>
      <last_name>Guillaume CARTRON, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Hôtel Dieu</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steven LE GOUILL</last_name>
      <email>steven.legouill@chu-nantes.fr</email>
    </contact>
    <investigator>
      <last_name>Steven LE GOUILL, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHR de la Source</name>
      <address>
        <city>ORLEANS cedex 2</city>
        <zip>45067</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Omar BENBRAHIM</last_name>
    </contact>
    <contact_backup>
      <email>omar.benbrahim@chr-orleans.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Omar BENBRAHIM, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint Louis</name>
      <address>
        <city>Paris cedex 10</city>
        <zip>75475</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine THIEBLEMONT</last_name>
      <email>catherine.thieblemont@sls.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Catherine THIEBLEMONT, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Saint Antoine</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zora MARJANOVIC</last_name>
      <email>zora.marjanovic@sat.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Zora MARJANOVIC, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital de la Pitié Salpêtrière</name>
      <address>
        <city>Paris</city>
        <zip>75651</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean GABARRE</last_name>
      <email>jean.gabarre@psl.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Jean GABARRE, doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Necker</name>
      <address>
        <city>Paris</city>
        <zip>75743</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard DELARUE</last_name>
      <email>richard.delarue@nck.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Richard DELARUE, doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Perpignan</name>
      <address>
        <city>Perpignan</city>
        <zip>66046</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurence SAHNES</last_name>
      <email>laurence.sanhes@ch-perpignan.fr</email>
    </contact>
    <investigator>
      <last_name>Laurence SANHES, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Haut Lévêque</name>
      <address>
        <city>Pessac</city>
        <zip>33604</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Krimo BOUABDALLAH</last_name>
      <email>krimo.bouabdallah@chu-bordeaux.fr</email>
    </contact>
    <investigator>
      <last_name>Krimo BOUABDALLAH, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Lyon Sud</name>
      <address>
        <city>Pierre Bénite cedex</city>
        <zip>69495</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gilles SALLES</last_name>
      <email>gilles.salles@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Gilles SALLES, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Robert Debre</name>
      <address>
        <city>Reims</city>
        <zip>51092</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alain DELMER</last_name>
      <email>adelmer@chu-reims.fr</email>
    </contact>
    <investigator>
      <last_name>Alain DELMER, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Pontchaillou</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thierry LAMY de la CHAPELLE</last_name>
      <email>thierry.lamy.de.la.chapelle@chu-rennes.fr</email>
    </contact>
    <investigator>
      <last_name>Thierry LAMY de la CHAPELLE, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Henri Becquerel</name>
      <address>
        <city>Rouen</city>
        <zip>76038</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hervé TILLY</last_name>
      <email>herve.tilly@chb.unicancer.fr</email>
    </contact>
    <investigator>
      <last_name>Hervé TILLY, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Saint Quentin</name>
      <address>
        <city>Saint Quentin</city>
        <zip>02321</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Réda GARIDI</last_name>
      <email>r.garidi@ch-stquentin.fr</email>
    </contact>
    <investigator>
      <last_name>Réda GARIDI, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut de cancérologie de la Loire</name>
      <address>
        <city>St priest en jarez</city>
        <zip>42271</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christiane MOUNIER</last_name>
      <email>christiane.mounier@icloire.fr</email>
    </contact>
    <investigator>
      <last_name>Christiane MOUNIER, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luc Matthieu FORNECKER</last_name>
      <email>luc-matthieu.fornecker@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Luc-Matthieu FORNECKER, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Purpan</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lucie OBERIC</last_name>
      <email>oberic.l@chu-toulouse.fr</email>
    </contact>
    <investigator>
      <last_name>Lucie OBERIC</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Bretonneau</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caroline DARTIGEAS</last_name>
      <email>c.dartigeas@chu-tours.fr</email>
    </contact>
    <investigator>
      <last_name>Caroline DARTIGEAS, doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Nancy Brabois</name>
      <address>
        <city>Vandoeuvre Les Nancy</city>
        <zip>54511</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>PIERRE FEUGIER</last_name>
      <email>p.feugier@chu-nancy.fr</email>
    </contact>
    <investigator>
      <last_name>Pierre FEUGIER, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Gustave Roussy</name>
      <address>
        <city>Villejuif</city>
        <zip>94805</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vincent RIBRAG</last_name>
      <email>vincent.ribrag@gustaveroussy.fr</email>
    </contact>
    <investigator>
      <last_name>Vincent RIBRAG, doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gesundheitszentrum St. Marien GmbH</name>
      <address>
        <city>Amberg</city>
        <zip>92224</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ludwig Fischer v. Weikersthal, MD</last_name>
      <email>weikersthal.ludwig@gesundheitszentrum.klinikum-amberg.de</email>
    </contact>
    <investigator>
      <last_name>Ludwig Fischer v. Weikersthal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Charite´ Universitätsmedizin Berlin Campus Benjamin Franklin</name>
      <address>
        <city>Berlin</city>
        <zip>12200</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio Pezzutto, Prof.</last_name>
    </contact>
    <investigator>
      <last_name>Antonio Pezzutto, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Charite´Universitätsmedizin Berlin Campus Virchow-Klinikum</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas Loew, MD</last_name>
      <email>andreas.loew@charite.de</email>
    </contact>
    <investigator>
      <last_name>Andreas Loew, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Städt. Klinikum Braunschweig gGmbH</name>
      <address>
        <city>Braunschweig</city>
        <zip>38114</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jürgen Krauter, Prof.</last_name>
      <email>medklinik3@klinikum-braunschweig.de</email>
    </contact>
    <investigator>
      <last_name>Jürgen Krauter, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>DIAKO Ev. Diakonie-Krankenhaus gemeinnützige GmbH</name>
      <address>
        <city>Bremen</city>
        <zip>28239</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ralf Trappe, MD</last_name>
      <email>r.trappe@@diako-bremen.de</email>
    </contact>
    <investigator>
      <last_name>Ralf Trappe, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum Chemnitz gGmbH</name>
      <address>
        <city>Chemnitz</city>
        <zip>9116</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mathias Hänel, MD</last_name>
      <email>m.haenel@skc.de</email>
    </contact>
    <investigator>
      <last_name>Mathias Hänel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Marien Hospital Düsseldorf</name>
      <address>
        <city>Düsseldorf</city>
        <zip>40479</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aristoteles GIAGOUNIDIS, MD</last_name>
    </contact>
    <investigator>
      <last_name>Aristoteles GIAGOUNIDIS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Antonius Hospital</name>
      <address>
        <city>Eschweiler</city>
        <zip>52249</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Staib, MD</last_name>
      <email>peter.staib@sah-eschweiler.de</email>
    </contact>
    <investigator>
      <last_name>Peter Staib, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Essen</name>
      <address>
        <city>Essen</city>
        <zip>45147</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Dürig, Prof.</last_name>
      <email>jan.duerig@uk-essen.de</email>
    </contact>
    <investigator>
      <last_name>Jan Dürig, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum Frankfurt GmbH</name>
      <address>
        <city>Frankfurt (Oder)</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arkadius Gawliczek, MD</last_name>
    </contact>
    <investigator>
      <last_name>Arkadius Gawliczek, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin Greifswald</name>
      <address>
        <city>Greifswald</city>
        <zip>17475</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Andreas Schmidt, Prof.</last_name>
      <email>christian.schmidt@uni-greifswald.de</email>
    </contact>
    <investigator>
      <last_name>Christian Andreas Schmidt, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kath. Krankenhaus Hagen gem. GmbH</name>
      <address>
        <city>Hagen</city>
        <zip>58095</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hans-Walter Lindemann, MD</last_name>
      <email>w.lindemann@kkh-hagen.de</email>
    </contact>
    <investigator>
      <last_name>Hans-Walter Lindemann, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Judith Dierlamm, Prof.</last_name>
      <email>dierlamm@uke.de</email>
    </contact>
    <investigator>
      <last_name>Judith Dierlamm, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum Herford</name>
      <address>
        <city>Herford</city>
        <zip>32049</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephan Bildat, MD</last_name>
      <email>stephan.bildat@klinikum-herford.de</email>
    </contact>
    <investigator>
      <last_name>Stephan Bildat, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum des Saarlandes</name>
      <address>
        <city>Homburg/Saar</city>
        <zip>66421</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Pfreundschuh, Prof</last_name>
      <email>Michael.Pfreundschuh @uks.eu</email>
    </contact>
    <investigator>
      <last_name>Michael Pfreundschuh, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Städt. Klinikum Karlsruhe</name>
      <address>
        <city>Karlsruhe</city>
        <zip>76133</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Bentz, Prof.</last_name>
      <email>martin.bentz@klinikum-karlsruhe.de</email>
    </contact>
    <investigator>
      <last_name>Martin Bentz, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Uni-Klinikum-Schleswig-Holstein im Städt. Krankenhaus Kiel</name>
      <address>
        <city>Kiel</city>
        <zip>24116</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christiane Pott, MD</last_name>
      <email>c.pott@med2.uni-kiel.de</email>
    </contact>
    <investigator>
      <last_name>Christiane Pott, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Internistische Praxis /Hämatologie und Onkologie</name>
      <address>
        <city>Kronach</city>
        <zip>96317</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martina Stauch, MD</last_name>
      <email>drm@drstauch.de</email>
    </contact>
    <investigator>
      <last_name>Martina Stauch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Köln</name>
      <address>
        <city>Köln</city>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kai Hübel, Prof.</last_name>
      <email>kai.huebel@uk-koeln.de</email>
    </contact>
    <investigator>
      <last_name>Kai Hübel, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Onkologisches Zentrum - Lebach</name>
      <address>
        <city>Lebach</city>
        <zip>66822</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephan Kremers, MD</last_name>
      <email>stephankremers@onkologie-lebach.de</email>
    </contact>
    <investigator>
      <last_name>Stephan Kremers, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum Ludwigshafen</name>
      <address>
        <city>Ludwigshafen</city>
        <zip>67063</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Hoffmann, MD</last_name>
      <email>hoffmanm@klilu.de</email>
    </contact>
    <investigator>
      <last_name>Martin Hoffmann, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stauferklinikum Schwäbisch Gmünd</name>
      <address>
        <city>Mutlangen</city>
        <zip>73557</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Holger Hebart, Prof.</last_name>
      <email>holger.hebart@stauferklinikum.de</email>
    </contact>
    <investigator>
      <last_name>Holger Hebart, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kliniken Maria Hilf GmbH (Krankenhaus St. Franziskus)</name>
      <address>
        <city>Mönchengladbach</city>
        <zip>41063</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ullrich Graeven, Prof.</last_name>
      <email>ullrich.graeven@mariahilf.de</email>
    </contact>
    <investigator>
      <last_name>Ullrich Graeven, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum rechts der Isar der TU München</name>
      <address>
        <city>München</city>
        <zip>81675</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ulrich Keller, Prof.</last_name>
      <email>ulrich.keller@mri.tum.de</email>
    </contact>
    <investigator>
      <last_name>Ulrich Keller, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum der Universität München</name>
      <address>
        <city>München</city>
        <zip>83177</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Dreyling, Prof.</last_name>
      <email>martin.dreyling@med.uni-muenchen.de</email>
    </contact>
    <investigator>
      <last_name>Martin Dreyling, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis für Hämatologie und Onkologie</name>
      <address>
        <city>Münster</city>
        <zip>48149</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rüdiger Liersch, MD</last_name>
      <email>liersch@onkologie-muenster.de</email>
    </contact>
    <investigator>
      <last_name>Rüdiger Liersch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Münster</name>
      <address>
        <city>Münster</city>
        <zip>48149</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Georg Lenz, Prof</last_name>
      <email>georg.lenz@ukmuenster.de</email>
    </contact>
    <investigator>
      <last_name>Georg Lenz, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis für Hämatologie und internistische Onkologie</name>
      <address>
        <city>Neumarkt</city>
        <zip>92318</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ekkehart Ladda, MD</last_name>
      <email>eladda@onkologie-neumarkt.de</email>
    </contact>
    <investigator>
      <last_name>Ekkehart Ladda, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum Nürnberg</name>
      <address>
        <city>Nürnberg</city>
        <zip>90419</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Josef Birkmann, MD</last_name>
      <email>josef.birkmann@klinikum-nuernberg.de</email>
    </contact>
    <investigator>
      <last_name>Josef Birkmann, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis für Innere Medizin, Hämatologie und internistische Onkologie</name>
      <address>
        <city>Offenbach</city>
        <zip>63065</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hans-Peter Böck, MD</last_name>
      <email>boeck@onkologie-offenbach.de</email>
    </contact>
    <investigator>
      <last_name>Hans-Peter Böck, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brüderkrankenhaus St. Josef Paderborn</name>
      <address>
        <city>Paderborn</city>
        <zip>33098</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tobias Gaska, MD</last_name>
      <email>t.gaska@bk-paderborn.de</email>
    </contact>
    <investigator>
      <last_name>Tobias Gaska, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinik Rostock</name>
      <address>
        <city>Rostock</city>
        <zip>18057</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Große-Thie, MD</last_name>
      <email>christina.grosse-thie@med.uni-rostock.de</email>
    </contact>
    <investigator>
      <last_name>Christina Große-Thie, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mutterhaus der Borromäerinnen GmbH</name>
      <address>
        <city>Trier</city>
        <zip>54219</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rolf Mahlberg, MD</last_name>
      <email>mahlberg@mutterhaus.de</email>
    </contact>
    <investigator>
      <last_name>Rolf Mahlberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Tübingen</name>
      <address>
        <city>Tübingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Sökler</last_name>
      <email>martin.soekler@med.uni-tuebingen.de</email>
    </contact>
    <investigator>
      <last_name>Martin Sökler</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Ulm</name>
      <address>
        <city>Ulm</city>
        <zip>89081</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephan Stilgenbauer, Prof.</last_name>
      <email>stephan.stilgenbauer@uniklinik-ulm.de</email>
    </contact>
    <investigator>
      <last_name>Stephan Stilgenbauer, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MC Alkmaar</name>
      <address>
        <city>Alkmaar</city>
        <zip>1800AM</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hein Visser</last_name>
      <email>h.visser@nwz.nl</email>
    </contact>
    <investigator>
      <last_name>Hein Visser</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>VUMC</name>
      <address>
        <city>Amsterdam</city>
        <zip>1007 MB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Josée Zijlstra-Baalbergen, MD</last_name>
      <email>j.zijlstra@vumc.nl</email>
    </contact>
    <investigator>
      <last_name>Josée Zijlstra-Baalbergen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>OLVG</name>
      <address>
        <city>Amsterdam</city>
        <zip>1090 HM</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>W Terpstra</last_name>
    </contact>
    <investigator>
      <last_name>W Terpstra</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AMC</name>
      <address>
        <city>Amsterdam</city>
        <zip>1100 DD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie José KERSTEN</last_name>
      <email>m.j.kersten@amc.uva.nl</email>
    </contact>
    <investigator>
      <last_name>Marie José KERSTEN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Amphia ziekenhuis, locatie Langendijk</name>
      <address>
        <city>Breda</city>
        <zip>4800 RL</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joost VAN ESSER</last_name>
      <email>esserj@amphia.nl</email>
    </contact>
    <investigator>
      <last_name>Joost VAN ESSER</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Reinier de Graaf Gasthuis</name>
      <address>
        <city>Delft</city>
        <zip>2600 GA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rolf BROUWER</last_name>
      <email>brouwer@rdgg.nl</email>
    </contact>
    <investigator>
      <last_name>Rolf BROUWER</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jeroen Bosch ziekenhuis</name>
      <address>
        <city>Den Bosch</city>
        <zip>5200 ME</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hans PRUIJT</last_name>
      <email>h.pruijt@jbz.nl</email>
    </contact>
    <investigator>
      <last_name>Hans PRUIJT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hagaziekenhuis, locatie Leyweg</name>
      <address>
        <city>Den Haag</city>
        <zip>2504 LN</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lara BOHMER</last_name>
      <email>l.h.bohmer@hagaziekenhuis.nl</email>
    </contact>
    <investigator>
      <last_name>Lara BOHMER</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gemini Ziekenhuis</name>
      <address>
        <city>Den Helder</city>
        <zip>1780 AT</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arie VAN DER SPEK</last_name>
      <email>A.C.vanderSpek@gemini-ziekenhuis.nl</email>
    </contact>
    <investigator>
      <last_name>Arie VAN DER SPEK</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medisch Spectrum Twente</name>
      <address>
        <city>Enschede</city>
        <zip>7500 KA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tjeerd SNIJDERS</last_name>
      <email>sigo@mst.nl</email>
    </contact>
    <investigator>
      <last_name>Tjeerd SNIJDERS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zuyderland MC</name>
      <address>
        <city>Geleen</city>
        <zip>6130 MB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roel VAN KAMPEN</last_name>
      <email>r.vankampen@orbisconcern.nl</email>
    </contact>
    <investigator>
      <last_name>Roel VAN KAMPEN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Admiraal De Ruyter Ziekenhuis, Goes</name>
      <address>
        <city>Goes</city>
        <zip>4460 BB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yavuz BILGIN</last_name>
      <email>y.bilgin@adrz.nl</email>
    </contact>
    <investigator>
      <last_name>Yavuz BILGIN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Groene Hart Ziekenhuis</name>
      <address>
        <city>Gouda</city>
        <zip>2800 BB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bea TANIS</last_name>
      <email>bea.tanis@ghz.nl</email>
    </contact>
    <investigator>
      <last_name>Bea TANIS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UMCG</name>
      <address>
        <city>Groningen</city>
        <zip>9700 RB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcel Nijland</last_name>
      <email>m.nijland@umcg.nl</email>
    </contact>
    <investigator>
      <last_name>Marcel Nijland</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spaarne ziekenhuis</name>
      <address>
        <city>Hoofddorp</city>
        <zip>2130 AT</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aart BEEKER</last_name>
      <email>abeeker@spaarneziekenhuis.nl</email>
    </contact>
    <investigator>
      <last_name>Aart BEEKER</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MC Leeuwarden Zuid</name>
      <address>
        <city>Leeuwarden</city>
        <zip>8901 BR</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mels HOOGENDOORN</last_name>
      <email>m.hoogendoorn@znb.nl</email>
    </contact>
    <investigator>
      <last_name>Mels HOOGENDOORN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Maastricht UMC</name>
      <address>
        <city>Maastricht</city>
        <zip>6202 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Harry SCHOUTEN</last_name>
      <email>harry.schouten@mumc.nl</email>
    </contact>
    <investigator>
      <last_name>Harry SCHOUTEN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sint Antonius Ziekenhuis</name>
      <address>
        <city>Nieuwegein</city>
        <zip>3430 EM</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Josephine VOS</last_name>
      <email>jm.vos@antoniusziekenhuis.nl</email>
    </contact>
    <investigator>
      <last_name>Josephine VOS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Radboudumc</name>
      <address>
        <city>Nijmegen</city>
        <zip>6525 GA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wendy Stevens</last_name>
      <email>W.Stevens@hemat.umcn.nl</email>
    </contact>
    <investigator>
      <last_name>Wendy Stevens</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bravis ziekenhuis</name>
      <address>
        <city>Roosendaal</city>
        <zip>4700 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole VAN DEN BURG-DE GRAAUW</last_name>
      <email>n.degraauw@bravis.nl</email>
    </contact>
    <investigator>
      <last_name>Nicole VAN DEN BURG-DE GRAAUW</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Erasmus MC - Centrum</name>
      <address>
        <city>Rotterdam</city>
        <zip>3000 CA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elly LUGTENBURG</last_name>
      <email>p.lugtenburg@erasmusmc.nl</email>
    </contact>
    <investigator>
      <last_name>Elly LUGTENBURG</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Erasmus MC - Daniel</name>
      <address>
        <city>Rotterdam</city>
        <zip>3008 AE</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeanette Doorduijn</last_name>
      <email>j.doorduijn@erasmusmc.nl</email>
    </contact>
    <investigator>
      <last_name>Jeanette Doorduijn</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Maasstadziekenhuis</name>
      <address>
        <city>Rotterdam</city>
        <zip>3079 DZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rineke Leys</last_name>
    </contact>
    <investigator>
      <last_name>Rineke Leys</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St.Elisabeth ZH</name>
      <address>
        <city>Tilburg</city>
        <zip>5000 LC</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc DURIAN</last_name>
      <email>m.durian@etz.nl</email>
    </contact>
    <investigator>
      <last_name>Marc DURIAN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Isala Klinieken, Sophia</name>
      <address>
        <city>Zwolle</city>
        <zip>8000 GK</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marinus VAN MARWIJK KOOY</last_name>
      <email>m.van.marwijk@isala.nl</email>
    </contact>
    <investigator>
      <last_name>Marinus VAN MARWIJK KOOY</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gdansk University School of Medicine</name>
      <address>
        <city>Gdańsk</city>
        <zip>80-211</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michal Taszner</last_name>
    </contact>
    <investigator>
      <last_name>Michal Taszner</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Szpitale Wojewódzkie</name>
      <address>
        <city>Gdynia</city>
        <zip>81-519</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jan Maciej Zaucha</last_name>
    </contact>
    <investigator>
      <last_name>Jan Maciej Zaucha</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Kraków</city>
        <zip>31-501</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Wojciech Jurczak</last_name>
    </contact>
    <investigator>
      <last_name>Wojciech SJurczak</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Warminsko-Mazurskie Centrum Onkologii</name>
      <address>
        <city>Olsztyn</city>
        <zip>10-228</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Wanda Knopinska-Posluszny</last_name>
      <email>wanda.knopinska@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Wanda Knopinska-Posluszny</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institute of Hematology and Transfusiology</name>
      <address>
        <city>Warszawa</city>
        <zip>02-776</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ewa Lech-Marańda</last_name>
      <email>ewamaranda@wp.pl</email>
    </contact>
    <investigator>
      <last_name>Ewa Lech-Marańda</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MSCM Institute and Oncology Centre</name>
      <address>
        <city>Warszawa</city>
        <zip>02-781</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jan Walewski</last_name>
      <email>walewski@coi.waw.pl</email>
    </contact>
    <investigator>
      <last_name>Jan Walewski</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Instituto Português de Oncologia de Lisboa de Francisco Gentil</name>
      <address>
        <city>Lisboa</city>
        <zip>1099-023</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria GOMES DA SILVA, MD</last_name>
      <email>mgsilva@ipolisboa.min-saude.pt</email>
    </contact>
    <investigator>
      <last_name>Maria GOMES DA SILVA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Fundación Alcorcón</name>
      <address>
        <city>Alcorcón</city>
        <zip>28922</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Javier Peñalver</last_name>
      <email>fjpenalver@fhalcorcon.es</email>
    </contact>
    <investigator>
      <last_name>Javier Peñalver</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Catala d'Oncologia (ICO) - Hospital Germans Trias y Pujol</name>
      <address>
        <city>Badalona</city>
        <zip>8916</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Manuel Sancho</last_name>
      <email>jsancho@iconcologia.net</email>
    </contact>
    <investigator>
      <last_name>Juan Manuel Sancho</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Vall d'hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>8035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana Marin-Niebla</last_name>
      <email>ana.marin@vhebron.net</email>
    </contact>
    <investigator>
      <last_name>Ana Marin-Niebla</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clínic</name>
      <address>
        <city>Barcelona</city>
        <zip>8036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eva Giné Soca</last_name>
      <email>egine@clinic.cat</email>
    </contact>
    <investigator>
      <last_name>Eva Giné Soca</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital San Pedro de Alcántara</name>
      <address>
        <city>Cáceres</city>
        <zip>10003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fernando Carnicero</last_name>
      <email>fcarnicero@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Fernando Carnicero</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Ramón y Cajal</name>
      <address>
        <city>Madrid</city>
        <zip>28034</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Javier López</last_name>
      <email>jlopezj.hrc@salud.madrid.org</email>
    </contact>
    <investigator>
      <last_name>Javier López</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario 12 de Octubre</name>
      <address>
        <city>Madrid</city>
        <zip>28041</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carlos Grande</last_name>
      <email>cgrandegar@yahoo.es</email>
    </contact>
    <investigator>
      <last_name>Carlos Grande</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Central de Asturias</name>
      <address>
        <city>Oviedo</city>
        <zip>33011</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Concha Nicolás</last_name>
      <email>conchanicolas61@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Concha Nicolás</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clínica Universidad de Navarra</name>
      <address>
        <city>Pamplona</city>
        <zip>31008</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carlos Panizo</last_name>
      <email>cpanzio@unav.es</email>
    </contact>
    <investigator>
      <last_name>Carlos Panizo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico de Salamanca</name>
      <address>
        <city>Salamanca</city>
        <zip>37007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alejandro Martin</last_name>
    </contact>
    <investigator>
      <last_name>Alejandro Martin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico de Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria José Terol</last_name>
    </contact>
    <investigator>
      <last_name>Maria José Terol</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
    <country>Germany</country>
    <country>Netherlands</country>
    <country>Poland</country>
    <country>Portugal</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 24, 2013</study_first_submitted>
  <study_first_submitted_qc>May 29, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 30, 2013</study_first_posted>
  <last_update_submitted>March 6, 2018</last_update_submitted>
  <last_update_submitted_qc>March 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Mantle Cell Lymphoma</keyword>
  <keyword>RCHOP</keyword>
  <keyword>RHAD</keyword>
  <keyword>rituximab</keyword>
  <keyword>lenalidomide</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphoma</mesh_term>
    <mesh_term>Lymphoma, Mantle-Cell</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lenalidomide</mesh_term>
    <mesh_term>Rituximab</mesh_term>
    <mesh_term>Thalidomide</mesh_term>
    <mesh_term>Cyclophosphamide</mesh_term>
    <mesh_term>Prednisone</mesh_term>
    <mesh_term>Vincristine</mesh_term>
    <mesh_term>Doxorubicin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

